Medscape9h
FDA OKs First Adaptive DBS System for Parkinson’s Disease
The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized ...
FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy ...
Hosted on MSN2h
FDA-approved technology offers personalized treatment for Parkinson’s symptoms
Starting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration ...
MassDevice13h
Medtronic wins first FDA nod for adaptive DBS for Parkinson’s
(NYSE: MDT) announced today that the FDA approved its BrainSense adaptive deep brain stimulation (aDBS) platform.
Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's
For the one million people diagnosed with Parkinson's disease in the United States1, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...
Asian Development Bank11d
Q&A: Transforming ADB’s Gender Mainstreaming Approaches
Given that ADB has significantly surpassed Strategy 2030’s gender mainstreaming targets, the bank is raising its ambition to further accelerate progress and promote more transformative approaches to ...
Asian Development Bank12d
ADB's North American Representative Office Celebrates 30 Years of Partnership
The Asian Development Bank's North American Representative Office (NARO) is celebrating its 30th anniversary in 2025. This milestone celebrates three decades of fostering meaningful partnership with ...
Pharm Exec8h
FDA Approves Medtronic’s BrainSense Adaptive Deep Brain Stimulation for Parkinson Disease
The BrainSense adaptive deep brain stimulation system personalizes therapy by dynamically adjusting stimulation based on real ...
Hosted on MSN3h
FDA approves Medtronic’s brain stimulation system for Parkinson’s
The FDA’s authorisation of Medtronic’s BrainSense follows the system’s receipt of a CE mark in Europe last month.
Medtronic’s BrainSense brain stimulation system approved by FDA for Parkinson’s
Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no ...
Medtronic plc: Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's
New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever ...